Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 12, 2013 - Issue 3
Submit an article Journal homepage
800
Views
10
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Safety evaluation of desloratadine in allergic rhinitis

Vanesa González-NúñezHospital Quirón, Department of Allergology, Barcelona, Catalonia, Spain
, MD,
Antonio ValeroAllergy Unit, Department of Pneumology and Respiratory Allergy, ICT, Hospital Clínic i Universitari, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Catalonia, Spain
, MD PhD &
Joaquim MullolRhinology Unit & Smell Clinic, Department of Otorhinolaryngology, Hospital Clínic i Universitari, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and CIBER de Enfermedades Respiratorias (CIBERES), C/Villarroel 170, 08036 Barcelona, Catalonia, [email protected]
, MD PhD
Pages 445-453 | Published online: 11 Apr 2013

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jeltje Boer, Ellen Ederveen & Birgitta Grundmark. (2018) Desloratadine and depression, a drug safety signal based on worldwide spontaneous reporting of side effects. Upsala Journal of Medical Sciences 123:3, pages 174-178.
Read now
Vanesa González-Núñez, Claus Bachert & Joaquim Mullol. (2016) Rupatadine: global safety evaluation in allergic rhinitis and urticaria. Expert Opinion on Drug Safety 15:10, pages 1439-1448.
Read now

Articles from other publishers (8)

Tian Wang, Boya Hao, Shilin Xu, Jie Meng, Tao Wen, Jian Liu & Haiyan Xu. (2022) Effective RNAi in leukemia cells is enhanced by spermine-modified pullulan combined with desloratadine. Carbohydrate Polymers 292, pages 119646.
Crossref
Annette Kjær Ersbøll, Kaushik Sengupta, Eero Pukkala, Kristian Bolin, Eline Aas, Martha Emneus, Dena Rosen Ramey, Joanne E. Brady, Daniel Mines, Kristian Aasbjerg, Christian Vestergaard, Gunnar Gislason, Alfred Peter Born & Thora Majlund Kjærulff. (2021) Desloratadine Exposure and Incidence of Seizure: A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001–2015. Drug Safety 44:11, pages 1231-1242.
Crossref
Yurii Marushko & Olha Khomych. (2021) Efficacy and Safety for Use Desloratadine in Children with Allergic Conditions (Literature Review, Own Research). Family medicine:5-6, pages 84-88.
Crossref
Yuxin Zhang, Yihua Lu, Lijuan Wang, Yuan Tian & Zunjian Zhang. (2020) Pharmacokinetics and Tissue Distribution of Loratadine, Desloratadine and Their Active Metabolites in Rat based on a Newly Developed LC-MS/MS Analytical Method. Drug Research 70:11, pages 528-540.
Crossref
Tadaho Nakamura, Kotaro Hiraoka, Ryuichi Harada, Takuro Matsuzawa, Yoichi Ishikawa, Yoshihito Funaki, Takeo Yoshikawa, Manabu Tashiro, Kazuhiko Yanai & Nobuyuki Okamura. (2019) Brain histamine H 1 receptor occupancy after oral administration of desloratadine and loratadine . Pharmacology Research & Perspectives 7:4.
Crossref
Gema Tarrasón, Carla Carcasona, Peter Eichhorn, Bibiana Pérez, Amadeu Gavaldà & Núria Godessart. (2017) Characterization of the chloroquine‐induced mouse model of pruritus using an automated behavioural system. Experimental Dermatology 26:11, pages 1105-1111.
Crossref
Eva Wex, Eva Thaler, Sylvia Blum & David Lamb. (2014) A Novel Model of IgE-Mediated Passive Pulmonary Anaphylaxis in Rats. PLoS ONE 9:12, pages e116166.
Crossref
Katherine A. Lyseng-Williamson. (2014) Desloratadine: a guide to its use in allergic disorders. Drugs & Therapy Perspectives 30:2, pages 35-41.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.